COVID-19 and Drug Shortages: A Call to Action

J Manag Care Spec Pharm. 2020 Aug;26(8):945-947. doi: 10.18553/jmcp.2020.26.8.945.

Abstract

The ever-vulnerable medication supply chain is being further strained by the COVID-19 pandemic. Pharmacists in all settings, including managed care, will need to prepare for a potential exacerbation of existing and new drug shortages in the midst of unprecedented crisis. We summarize the major issues, discuss potential mitigation strategies, and call on our colleagues to respond with the resilience necessary to protect our patients. DISCLOSURES: The authors declare no funding sources nor conflicts of interest.

MeSH terms

  • COVID-19
  • Coronavirus Infections / drug therapy*
  • Humans
  • Pandemics
  • Pharmaceutical Preparations / supply & distribution*
  • Pharmacies / ethics
  • Pharmacies / statistics & numerical data*
  • Pharmacists
  • Pharmacy Service, Hospital
  • Pneumonia, Viral / drug therapy*

Substances

  • Pharmaceutical Preparations